EHC Stock Analysis: Buy, Sell, or Hold?
EHC - Encompass Health Corporation Common Stock
$110.71
0.55 (0.49%)
▲
5d:
+3.47%
30d:
+7.12%
90d:
+3.22%
BUY
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 03, 2026
20d
Get Alerted When EHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EHC shows positive signals but monitor for confirmation. Market pricing in 0.4% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: EHC shows positive signals but monitor for confirmation. Market pricing in 0.4% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$147.93
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$91.85
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EHC is currently trading at $110.70, which is considered extended relative to its 30-day fair value range of $99.05 to $106.64. The stock's valuation (Forward PE: 16.9) is in line with its historical norms (16.6). At these levels, the market is pricing in 0.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EHC is showing sideways momentum. The price is approaching resistance at $106.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EHC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $140.50 (+27.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EHC is showing sideways momentum. The price is approaching resistance at $106.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EHC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $140.50 (+27.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$99.05 -
$106.64
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.5% below Wall St target ($140.50)
- NEUTRAL: Market pricing in 0.4% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$99.05 -
$106.64
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$99.78
Resistance Level
$106.92
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.85
Wall Street Target
$140.50
(+27.5%)
Revenue Growth (YoY)
9.0%
Earnings Growth (YoY)
30.3%
Profit Margin
10.0%
Valuation Premium vs History
+0.4% premium
PE vs Historical
16.9 vs 16.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.4%
(market-implied from PE analysis)
1-Year Target
$110.60
(+0%)
2-Year Target
$111.04
(+1%)
3-Year Target
$111.49
(+1%)
3-Yr Target (if PE normalizes)
(PE: 17→17)
PE COMPRESSION
$109.86
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.8%)
$183.49
(+67%)
Base:
(SPY PE: 16.8, Growth: 8.8%)
$141.93
(+29%)
Bear:
(PE: 14.3, Growth: 8.8%)
$120.64
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 19.01 | Current EPS (TTM): $5.84
Bull Case
$136.74
(+24%)
Analyst growth 12.0%, PE expands to 20.9
Base Case
$124.31
(+13%)
Market implied 12.0%, PE stable at 19.0
Bear Case
$75.49
(-32%)
Severe decline -20.0%, PE contracts to 16.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 10:20 AM ET
Data refreshes hourly during market hours. Next update: 11:20 AM
Data refreshes hourly during market hours. Next update: 11:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Edmund Fay
SELL
11937 shares
2026-03-09
Mark J Tarr
SELL
150000 shares
2026-02-11
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 62 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$494 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 53 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 64 BUY |
|
UHS
Universal Health Service… |
HOLD
19 analysts |
$208 | 63 BUY |
